Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)
ClinicalTrials.gov study NCT05579132. IPD Sharing: YES. Countries: 1. Publications: 0.
N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT07049432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects
ClinicalTrials.gov study NCT01110863. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
ClinicalTrials.gov study NCT06564038. IPD Sharing: YES. Countries: 13. Publications: 0.
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
ClinicalTrials.gov study NCT06481735. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05421663. IPD Sharing: YES. Countries: 8. Publications: 0.
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00720135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma
ClinicalTrials.gov study NCT06149169. IPD Sharing: NO. Countries: 1. Publications: 0.
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT07024147. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
ClinicalTrials.gov study NCT03999697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors
ClinicalTrials.gov study NCT06662227. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuz
ClinicalTrials.gov study NCT03677154. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04657302. IPD Sharing: YES. Countries: 1. Publications: 0.
Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)
ClinicalTrials.gov study NCT04080245. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06723457. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies
ClinicalTrials.gov study NCT06703892. IPD Sharing: NO. Countries: 1. Publications: 0.
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
ClinicalTrials.gov study NCT06213636. IPD Sharing: NO. Countries: 1. Publications: 0.
B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma
ClinicalTrials.gov study NCT03246750. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare the Bioequivalence and Safety of JHL1101 and Rituximab in CD20 Positive B Cell Lymphoma Patients
ClinicalTrials.gov study NCT03670888. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBC
ClinicalTrials.gov study NCT02570542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.